Azelaic acid is one of the most effective topical treatments for rosacea, particularly for the bumps, pustules, and redness that define the condition. A 15% gel formulation is FDA-approved specifically for mild to moderate inflammatory rosacea, and clinical data shows it outperforms metronidazole, the other widely prescribed topical. Most people begin seeing improvement within 2 to 6 weeks.
How Azelaic Acid Targets Rosacea
Rosacea involves a chain of inflammatory processes in the skin, and azelaic acid interrupts several of them at once. It suppresses the production of reactive oxygen species from immune cells called neutrophils, which are a major driver of the redness and irritation characteristic of rosacea flares. It also blocks key inflammatory signaling pathways inside cells, reducing the release of pro-inflammatory molecules like interleukins and tumor necrosis factor.
What makes azelaic acid particularly well-suited for rosacea is its effect on two specific proteins: KLK5 and LL-37. These are part of an immune defense system that becomes overactive in rosacea-prone skin, triggering inflammation and visible flares. Azelaic acid also reduces expression of toll-like receptor 2 (TLR2), which sits upstream in this same cascade. By calming this entire pathway, it addresses the disease at a biological level rather than just masking symptoms.
Beyond inflammation, azelaic acid has mild antibacterial properties. It crosses bacterial cell membranes and disrupts their internal chemistry, which may help with the microbial imbalances some researchers associate with rosacea flares.
What the Clinical Results Look Like
In a head-to-head randomized trial comparing 15% azelaic acid gel to 0.75% metronidazole gel over 15 weeks, azelaic acid reduced inflammatory lesions by 72.7% compared to 55.8% for metronidazole. It also performed better on erythema (redness): 56% of patients using azelaic acid showed improvement in redness versus 42% on metronidazole. Both the investigators’ and patients’ own assessments favored azelaic acid.
One notable finding from that trial was the difference in how the two treatments progressed over time. Metronidazole appeared to plateau around week 8, while azelaic acid continued producing improvements through week 15. In a separate multicenter study, patients using an azelaic acid formulation saw their median inflammatory lesion count drop from 8 to 1 over 8 weeks, with erythema scores cut in half.
Which Type of Rosacea It Works Best For
The strongest evidence supports azelaic acid for papulopustular rosacea, the subtype characterized by red bumps and pus-filled lesions on the cheeks, nose, chin, and forehead. This is the form the FDA approval covers. The clinical trials consistently show significant reductions in both lesion counts and background redness in these patients.
For rosacea that presents mainly as persistent facial redness without bumps, the evidence is less robust but still encouraging. The erythema improvements seen in clinical trials suggest azelaic acid can help with redness on its own, though it is not specifically approved for that indication. It will not improve visible blood vessels (telangiectasia), which typically require laser or light-based treatments.
How to Use It
The standard application is a thin layer to affected areas twice daily, morning and evening. Most people apply it after cleansing and before moisturizer. If you experience stinging on initial application, applying moisturizer first as a buffer can reduce irritation without significantly affecting absorption.
Results take time. The Mayo Clinic notes that improvements with azelaic acid typically appear between 2 and 6 weeks, with continued gains through at least 15 weeks of consistent use. This is not a treatment where skipping days and restarting will give you the same results. Rosacea generally requires ongoing management, and clinical reviews describe azelaic acid as safe for long-term maintenance use, with side effects that are mostly mild or temporary and rarely require stopping treatment.
Side Effects to Expect
The gel formulation causes more local irritation than the cream or foam. In clinical trials, burning, stinging, or tingling affected up to 29% of gel users, while dryness, tightness, or scaling occurred in up to 19.4%. Itching was also common, reported by up to 19.4% of participants. These numbers sound high, but the reactions are generally mild and tend to diminish as your skin adjusts over the first week or two.
The cream and foam formulations produce similar types of side effects (burning, stinging, dryness, itching) but at lower rates, typically in the 1% to 10% range. If the gel proves too irritating, switching formulations is a reasonable option to discuss with your dermatologist. Serious side effects are rare across all formulations.
Prescription Strength vs. Over the Counter
The FDA-approved prescription product for rosacea is a 15% azelaic acid gel. A 20% cream formulation also exists but is approved for acne rather than rosacea. Over-the-counter products typically contain 10% azelaic acid or less, and while many people use them for rosacea management, they haven’t been tested in the same rigorous trials.
Interestingly, the 15% gel actually delivers more of the active ingredient into the skin than the 20% cream. Systemic absorption from the gel runs around 8%, compared to about 3% from the cream. The gel’s aqueous base enhances penetration, which is part of why it is both more effective and slightly more irritating.
Safety During Pregnancy
Azelaic acid holds an FDA pregnancy category B rating, making it one of the preferred topical options for pregnant individuals dealing with rosacea or acne. Animal studies have shown no harmful effects on fetuses even at high doses, and no adverse events have been reported from parenteral use in humans. Controlled studies in pregnant humans are still lacking, so current guidance recommends using it on small skin surfaces and preferably avoiding it during the first trimester as a precaution. For people whose rosacea flares during pregnancy, it remains one of the safest available treatments.